Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials (Galvano et al., J Bone Oncol 2019; 18:100252)
J Bone Oncol
.
2020 Apr 28:22:100295.
doi: 10.1016/j.jbo.2020.100295.
eCollection 2020 Jun.
Authors
Antonio Galvano
1
,
Dalila Scaturro
1
,
Viviana Bazan
2
,
Giulia Letizia Mauro
1
,
Antonio Russo
1
Affiliations
1
Department of Surgical, Oncological and Stomatological Sciences, University of Palermo, Italy.
2
Department of Biomedicine, Neuroscience and Advanced Diagnostics - University of Palermo, Palermo, Italy.
PMID:
32742917
PMCID:
PMC7385536
DOI:
10.1016/j.jbo.2020.100295
No abstract available